Mahmoud S Okasha MBBCh, MD, MRCPSYCH, DPM, DLFAPA

Associate Clinical Professor of Psychiatry

Research Interests

CNS:Alzheimers ,mood disorders,anxiety disorders,schizophrenia,ADHD

Current Projects

  • Bristol-Myers Squibb - Prodromal Alzheimers Disorder (Memory Loss) Phase II
  • Bristol-Myers Squibb - Treatment of patients with mild to moderate Alzheimers Disease
  • Pfizer - Major Depressive Adjunctive Therapy in MDD
  • Pfizer - Smoking Cessation - Chantix with MDD
  • Forest Pharmaceutical - Major Depressive Adjunctive Therapy in MDD
  • AstraZenaca - Major Depressive Adjunctive Therapy in MDD
  • Neuronetics - Transcranial Magnetic Stimulation Efficacy Trial

Selected Publications

  • 1978 Okasha, M.S., Hirsch, S.R., Knight, A. and Salih, M.A. Flupenthixol and Fluphenazine Decanoate: A Comparative Review PSYCHIATRIC ANNAL 8”7 (1978), 350-355
  • 1979 Knight, A., Okasha, M.S., Hirsch, S.R. and Salih, M.A. Depressive and Extrapyramidal Symptoms and Clinical Effects:A trial of Fluphenazine versus Flupenthixol in maintenance of schizophrenic outpatients. THE BRITISH JOURNAL OF PSYCHIATRY (December 1979) 515-523

Edit Profile